Platform
Features
Pricing
NATA - Nucleic Acid Therapy Accelerator
Edit position
Contact
No bio yet
Shalini Andersson
Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden)
Sign up to view 0 direct reports
Get started
4 members
7 members
This person is not in any offices
Ad
The Research Foundation for SUNY
Research Institute of Petroleum Industry (RIPI)
ClearlyRated
YouGov
Neurosensum